A Randomized Phase III Study of Docetaxel Plus Cisplatin Versus Pemetrexed Plus Cisplatin in First Line Non-Squamous Non-Small Cell Lung Cancer (Nsq-Nsclc)

Annals of Oncology ◽

10.1093/annonc/mdu438.49 ◽

2014 ◽

Vol 25 ◽

pp. v1 ◽

Author(s):

Y. Kim ◽

I. Oh ◽

K. Kim ◽

T. Jang ◽

Y.D. Choi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel + Carboplatin + Bevacizumab Followed by Maintenance Bevacizumab in Patients ith Advanced Nonsquamous Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1097/jto.0000000000000366 ◽

2015 ◽

Vol 10 (1) ◽

pp. 134-142 ◽

Author(s):

Ralph G. Zinner ◽

Coleman K. Obasaju ◽

David R. Spigel ◽

Robert W. Weaver ◽

J. Thaddeus Beck ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Open Label Phase ◽

Phase Iii Study

Download Full-text

PD4-2-3: Global Lung Oncology Branch trial 3 (Glob 3): final results of a randomised multinational Phase III study of oral and i.v. vinorelbine (NVB) plus cisplatin (CDDP) versus docetaxel (DTX) plus CDDP as first-line treatment for advanced Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000283381.78585.f2 ◽

2007 ◽

Vol 2 (8) ◽

pp. S451

Author(s):

Eng-Huat Tan ◽

Tomasz Grodzki ◽

Claus-Peter Schneider ◽

Peter Zatloukal ◽

Martin Reck ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Line Treatment ◽

Small Cell Lung ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

Abstract CT074: Tumor mutational burden (TMB) as a biomarker of survival in metastatic non-small cell lung cancer (mNSCLC): Blood and tissue TMB analysis from MYSTIC, a Phase III study of first-line durvalumab ± tremelimumab vs chemotherapy.

10.1158/1538-7445.sabcs18-ct074 ◽

2019 ◽

Author(s):

Solange Peters ◽

Byoung Chul Cho ◽

Niels Reinmuth ◽

Ki Hyeong Lee ◽

Alexander Luft ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Mutational Burden ◽

Tumor Mutational Burden ◽

Phase Iii Study

Download Full-text

Efficacy of chemotherapy after first-line gefitinib therapy in EGFR mutation-positive advanced non-small cell lung cancer--data from a randomized Phase III study comparing gefitinib with carboplatin plus paclitaxel (NEJ002)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyv054 ◽

2015 ◽

Vol 45 (7) ◽

pp. 670-676 ◽

Author(s):

E. Miyauchi ◽

A. Inoue ◽

K. Kobayashi ◽

M. Maemondo ◽

S. Sugawara ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Phase Iii ◽

Small Cell Lung ◽

Cancer Data ◽

Phase Iii Study

Download Full-text

Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer

Annals of Oncology ◽

10.1093/annonc/mdn774 ◽

2009 ◽

Vol 20 (7) ◽

pp. 1249-1256 ◽

Author(s):

E.H. Tan ◽

J. Rolski ◽

T. Grodzki ◽

C.P. Schneider ◽

U. Gatzemeier ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Line Treatment ◽

Small Cell Lung ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

P-452 Phase III study of docetaxel-cisplatin (DC) or docetaxel-carboplatin (DCb) versus vinorelbine-cisplatin (VC) as first-line treatment of advanced non-small cell lung cancer (NSCLC): Analyses by gender

Lung Cancer ◽

10.1016/s0169-5002(05)80945-6 ◽

2005 ◽

Vol 49 ◽

pp. S235 ◽

Author(s):

C. Belani ◽

J. von Pawel ◽

A. Pluzanska ◽

V. Gorbounova ◽

E. Kaukel ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Line Treatment ◽

Small Cell Lung ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

International multicenter randomized phase III study of first-line erlotinib (E) followed by second-line cisplatin plus gemcitabine (CG) versus first-line CG followed by second-line E in advanced non-small cell lung cancer (aNSCLC): The TORCH trial.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7508 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7508-7508 ◽

Author(s):

C. Gridelli ◽

F. Ciardiello ◽

R. Feld ◽

C. A. Butts ◽

V. Gebbia ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Second Line ◽

Small Cell Lung ◽

Phase Iii Study ◽

International Multicenter

Download Full-text

First-line crizotinib versus pemetrexed–cisplatin or pemetrexed–carboplatin in patients (pts) with advanced ALK-positive non-squamous non-small cell lung cancer (NSCLC): results of a phase III study (PROFILE 1014)

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.8002 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 8002-8002 ◽

Author(s):

Tony Mok ◽

Dong-Wan Kim ◽

Yi-Long Wu ◽

Benjamin J. Solomon ◽

Kazuhiko Nakagawa ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study ◽

Download Full-text

C1-06: BO17704: a phase III study of first-line cisplatin and gemcitabine with bevacizumab or placebo in patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC)

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000283193.48953.cd ◽

2007 ◽

Vol 2 (8) ◽

pp. S360-S361 ◽

Author(s):

Martin Reck ◽

Joachim von Pawel ◽

Petr Zatloukal ◽

Rodryg Ramlau ◽

Vera Gorbounova ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

LBA4 GEMSTONE-302: A phase III study of platinum-based chemotherapy (chemo) with placebo or CS1001, an anti-PDL1 antibody, for first-line (1L) advanced non-small cell lung cancer (NSCLC)

Annals of Oncology ◽

10.1016/j.annonc.2020.10.368 ◽

2020 ◽

Vol 31 ◽

pp. S1386

Author(s):

C. Zhou ◽

Z. Wang ◽

Y. Sun ◽

L. Cao ◽

Z. Ma ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Platinum Based Chemotherapy ◽

Phase Iii Study

Download Full-text